Emerald Health Therapeutics announces that its joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, has received from Health Canada its cannabis cultivation and sales licence based on an initial production area within its second 1.1 million square foot greenhouse facility in Delta, British Columbia allowing it to expand capacity as needed through successive license amendments. The Delta 2 facility is adjacent to its established, fully operating 1.1 million square foot Delta 3 greenhouse facility and, when in production, is expected to contribute to further lowering Pure Sunfarms’ already industry-leading cost of cultivation.
“The ongoing expansion of Pure Sunfarms’ cultivation capacity and extension of its product lines will continue to expand its flexibility and competitiveness to offer consumers choices that meet their preferences in form, quality, and value – which are already being met as seen through Pure Sunfarms’ stellar performance, for example, in Ontario1,” said Riaz Bandali, President and Chief Executive Officer of Emerald. “We expect Pure Sunfarms’ to continue to build on its operating and market leadership in its broad segment of the market.”
For more information:
Emerald Health Therapeutics
www.emeraldhealth.ca